Eyeworld

SEP 2020

EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.

Issue link: https://digital.eyeworld.org/i/1282091

Contents of this Issue

Navigation

Page 5 of 58

SEPTEMBER 2020 | EYEWORLD | 3 by Vance Thompson, MD Refractive Editor There are many reasons the eye is ideal to study genetic testing and therapy, and in this issue, we are fortunate to have leading experts in this exciting arena to educate and update us. Thomas Ciulla, MD, and Elliott Sohn, MD, teach us how and why gene therapy is making so much progress in ophthalmology. Mitchell Jackson, MD, William Trattler, MD, and Eliz- abeth Yeu, MD, update us on the progress of genetic testing for keratoconus. Tara Moore, PhD, and Albert Jun, MD, take us deeper into exploring corneal genetics and gene editing. Finally, Kapil Bharti, PhD, David Gamm, MD, PhD, Ula Jurkunas, MD, and Elliott Sohn, MD, educate us on stem cell replacement therapies for the eye. I think you will find these articles are a great way to educate and update yourself on the current status of genetic testing and gene therapy in the ophthalmology world today. Thank you to our wonderful group of doctors and the writers at EyeWorld who made this issue possible. I t has been said that the eyes are the windows to our soul. The key to unlocking the full potential of our visual performance and health is gene therapy and genetic testing. In this issue of EyeWorld, I think you will enjoy learning how genetic medicine has moved beyond rare disease and is head- ing toward quality treatments for some of the world's leading causes of blindness. Genetic testing is a type of medical test that identifies changes in a patient's chromosomes or genes. The results of a genetic test can confirm or rule out a suspected genetic condition or help determine a person's chance of developing a genetic disorder or passing it on to the next generation. There are many genetic tests cur- rently in use, and more are being developed. Gene therapy uses genes or genetic material (like nucleic acids) to treat or prevent disease. Gene therapy ASCRS is your trusted source for innovative education and philanthropy, for every stage of your career. Join today: ASCRS.org

Articles in this issue

Links on this page

Archives of this issue

view archives of Eyeworld - SEP 2020